Transcription and replication mechanisms of Bunyaviridae and Arenaviridae L proteins

Virus Research

Volumn 234, Issue , 2017, Pages 118-134

  Ferron, François ^a,b   Weber, Friedemann ^c   de la Torre, Juan Carlos ^d   Reguera, Juan ^a,b,e  

^a AIX MARSEILLE UNIVERSITY   (France)

^b CNRS   (France)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e Centre National de la Recherche Scientifique   (France)

Author keywords

Antivirals; Arenavirus; Bunyavirus; L protein; Replication; Transcription

Indexed keywords

ANTIVIRUS AGENT; RNA POLYMERASE; UNCLASSIFIED DRUG; VIRAL PROTEIN; VIRUS L PROTEIN; VIRUS NUCLEOPROTEIN; VIRUS RNA; VIRUS Z PROTEIN; NUCLEOPROTEIN; RNA DIRECTED RNA POLYMERASE;

ARENAVIRIDAE; ARENAVIRUS INFECTION; BUNYAVIRIDAE; BUNYAVIRUS INFECTION; CYTOPLASM; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RNA REPLICATION; RNA SYNTHESIS; VIRUS ENTRY; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY;

ARENAVIRIDAE; BUNYAVIRIDAE; HUMANS; NUCLEOPROTEINS; RNA REPLICASE; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 85011298614     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2017.01.018     Document Type: Review

References (190)

1. Överby, A.K., Pettersson, R.F., Grünewald, K., Huiskonen, J.T., Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus. Proc. Natl. Acad. Sci. 105 (2008), 2375–2379.
2. Albariño, C.G., Bird, B.H., Nichol, S.T., A shared transcription termination signal on negative and ambisense RNA genome segments of rift valley fever, sandfly fever sicilian, and toscana viruses. J. Virol. 81 (2007), 5246–5256.
3. Albornoz, A., Hoffmann, A., Lozach, P.-Y., Tischler, N., Early bunyavirus-Host cell interactions. Viruses, 8, 2016, 143.
4. Andrei, G., De Clercq, E., Molecular approaches for the treatment of hemorrhagic fever virus infections. Antivir. Res. 22 (1993), 45–75.
5. Barber, D.L., Wherry, E.J., Masopust, D., Zhu, B., Allison, J.P., Sharpe, A.H., Freeman, G.J., Ahmed, R., Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 (2006), 682–687.
6. Barr, J.N., Wertz, G.W., Bunyamwera bunyavirus RNA synthesis requires cooperation of 3’- and 5’-terminal sequences. J. Virol. 78 (2004), 1129–1138.
7. Barr, J.N., Bunyavirus mRNA synthesis is coupled to translation to prevent premature transcription termination. RNA N. Y. N 13 (2007), 731–736.
8. Bausch, D.G., Hadi, C.M., Khan, S.H., Lertora, J.J., Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin. Infect. Dis. 51 (2010), 1435–1441.
9. Bente, D.A., Forrester, N.L., Watts, D.M., McAuley, A.J., Whitehouse, C.A., Bray, M., Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 100 (2013), 159–189.
10. Beyer, W.R., Popplau, D., Garten, W., von Laer, D., Lenz, O., Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J. Virol. 77 (2003), 2866–2872.
11. Bodur, H., Erbay, A., Akıncı, E., Öngürü, P., Bayazıt, N., Eren, S.S., Kubar, A., Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis. 15 (2011), e44–47.
12. Boger, D.L., Ducray, P., Chai, W., Jiang, W., Goldberg, J., Higher order iminodiacetic acid libraries for probing protein–protein interactions. Bioorg. Med. Chem. Lett. 8 (1998), 2339–2344.
13. Boger, D.L., Solution-phase synthesis of combinatorial libraries designed to modulate protein–protein or protein-DNA interactions. Bioorg. Med. Chem. 11 (2003), 1607–1613.
14. Borden, K.L., Freemont, P.S., The RING finger domain: a recent example of a sequence-structure family. Curr. Opin. Struct. Biol. 6 (1996), 395–401 440X(96)80060-1.
15. Borio, L., Inglesby, T., Peters, C.J., Schmaljohn, A.L., Hughes, J.M., Jahrling, P.B., Ksiazek, T., Johnson, K.M., Meyerhoff, A., O'Toole, T., Ascher, M.S., Bartlett, J., Breman, J.G., Eitzen, E.M., Hamburg, M., Hauer, J., Henderson, D.A., Johnson, R.T., Kwik, G., Layton, M., Lillibridge, S., Nabel, G.J., Osterholm, M.T., Perl, T.M., Russell, P., Tonat, K., Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287 (2002), 2391–2405.
16. Bowden, T.A., Bitto, D., McLees, A., Yeromonahos, C., Elliott, R.M., Huiskonen, J.T., Orthobunyavirus ultrastructure and the curious tripodal glycoprotein spike. PLoS Pathog., 9, 2013.
17. Bray, M., Pathogenesis of viral hemorrhagic fever. Curr. Opin. Immunol. 17 (2005), 399–403.
18. Brennan, B., Weber, F., Kormelink, R., Schnettler, E., Bouloy, M., Failloux, A.-B., Weaver, S.C., Fazakerley, J.K., Fragkoudis, R., Harris, M., Barr, J.N., Palese, P., García-Sastre, A., Dalziel, R.G., Dutia, B.M., Lowen, A.C., Steel, J., Randall, R.E., Paul Duprex, W., Rice, C.M., Tesh, R.B., Murphy, F.A., Ebihara, H., Vasconcelos, P.F.C., Nunes, M.R., Fooks, A.R., Smith, G.L., Goodfellow, I., Pappu, H.R., Lamb, R.A., Paterson, R.G., Higgs, S., Vanlandingham, D.L., Dietzgen, R.G., Stephen Lodmell, J., Nichol, S.T., Daly, J., Ullman, D.E., Plyusnin, A., Plyusnina, A., Efstathiou, S., Hewson, R., Tordo, N., Cherry, S., Boutell, C., Hosie, M.J., Murcia, P.R., Neil, J.C., Palmarini, M., Patel, A.H., Willett, B.J., Kohl, A., McLauchlan, J., In memoriam –Richard M. elliott (1954–2015). J. Gen. Virol. 96 (2015), 1975–1978.
19. Brunotte, L., Kerber, R., Shang, W., Hauer, F., Hass, M., Gabriel, M., Lelke, M., Busch, C., Stark, H., Svergun, D.I., Betzel, C., Perbandt, M., Günther, S., Structure of the lassa virus nucleoprotein revealed by X-ray crystallography, small-angle X-ray scattering, and electron microscopy. J. Biol. Chem. 286 (2011), 38748–38756.
20. Brunotte, L., Lelke, M., Hass, M., Kleinsteuber, K., Becker-Ziaja, B., Gunther, S., Domain structure of Lassa virus L protein. J. Virol. 85 (2011), 324–333.
21. Buchmeier, M.J., Arenaviridae: the viruses and their replication. Knipe, D.M., (eds.) Fields Virology, fift edition, 2007, 1792–1827.
22. Cameron, C.E., Castro, C., The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase. Curr. Opin. Infect. Dis. 14 (2001), 757–764.
23. Cao, W., Henry, M.D., Borrow, P., Yamada, H., Elder, J.H., Ravkov, E.V., Nichol, S.T., Compans, R.W., Campbell, K.P., Oldstone, M.B., Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus [see comments]. Science 282 (1998), 2079–2081.
24. Capul, A.A., de la Torre, J.C., Buchmeier, M.J., Conserved residues in lassa fever virus z protein modulate viral infectivity at the level of the ribonucleoprotein. J. Virol. 85 (2011), 3172–3178.
25. Charrel, R.N., Gallian, P., Navarro-Marí, J.-M., Nicoletti, L., Papa, A., Sánchez-Seco, M.P., Tenorio, A., de Lamballerie, X., Emergence of toscana virus in europe. Emerg. Infect. Dis. 11 (2005), 1657–1663.
26. Cheng, B.Y., Ortiz-Riano, E., de la Torre, J.C., Martinez-Sobrido, L., Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells. J Vis Exp, 2013.
27. Chou, Y., Cuevas, C., Carocci, M., Stubbs, S.H., Ma, M., Cureton, D.K., Chao, L., Evesson, F., He, K., Yang, P.L., Whelan, S.P., Ross, S.R., Kirchhausen, T., Gaudin, R., Identification and characterization of a novel broad-Spectrum virus entry inhibitor. J. Virol. 90 (2016), 4494–4510.
28. Chung, D.-H., Kumarapperuma, S.C., Sun, Y., Li, Q., Chu, Y.-K., Arterburn, J.B., Parker, W.B., Smith, J., Spik, K., Ramanathan, H., Schmaljohn, C.S., Jonsson, C.B., Synthesis of 1-β-D-ribofuranosyl-3-ethynyl-[1, 2, 4]triazole and its in vitro and in vivo efficacy against Hantavirus. Antiviral Res. 79 (2008), 19–27.
29. Cleaveland, S., Haydon, D.T., Taylor, L., Overviews of pathogen emergence: which pathogens emerge, when and why?. Curr. Top. Microbiol. Immunol. 315 (2007), 85–111.
30. Clegg, J.C., Influence of climate change on the incidence and impact of arenavirus diseases: a speculative assessment. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 15 (2009), 504–509.
31. Cornu, T.I., de la Torre, J.C., RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. J. Virol. 75 (2001), 9415–9426.
32. Crotty, S., Maag, D., Arnold, J.J., Zhong, W., Lau, J.Y.N., Hong, Z., Andino, R., Cameron, C.E., The broad-spectrum antiviral ribonucleotide, ribavirin, is an RNA virus mutagen. Nat. Med. 6 (2000), 1375–1379.
33. Damonte, E.B., Coto, C.E., Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy. Adv. Virus Res. 58 (2002), 125–155.
34. Devignot, S., Bergeron, E., Nichol, S., Mirazimi, A., Weber, F., A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus. J. Virol. 89 (2015), 5957–5967.
35. Dias, A., Bouvier, D., Crépin, T., McCarthy, A.A., Hart, D.J., Baudin, F., Cusack, S., Ruigrok, R.W.H., The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 458 (2009), 914–918.
36. Eckerle, L.D., Becker, M.M., Halpin, R.A., Li, K., Venter, E., Lu, X., Scherbakova, S., Graham, R.L., Baric, R.S., Stockwell, T.B., Spiro, D.J., Denison, M.R., Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog., 6, 2010, e1000896.
37. Ellenbecker, M., Sears, L., Li, P., Lanchy, J.-M., Lodmell, J.S., Characterization of RNA aptamers directed against the nucleocapsid protein of Rift Valley fever virus. Antiviral Res. 93 (2012), 330–339.
38. Ellenbecker, M., Lanchy, J.-M., Lodmell, J.S., Inhibition of rift valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin. Antimicrob. Agents Chemother. 58 (2014), 7405–7415.
39. Ellenbecker, M., St Goddard, J., Sundet, A., Lanchy, J.-M., Raiford, D., Lodmell, J.S., Computational prediction and biochemical characterization of novel RNA aptamers to Rift Valley fever virus nucleocapsid protein. Comput. Biol. Chem. 58 (2015), 120–125.
40. Elliott, Blakqori, Molecular biology of orthobunyaviruses. Elliott, R.M., Plyusnin, A.R.M., (eds.) Bunyaviridae, Molecular and Cellular Biology, 2011, Caister Academic Press, Norkfolk, UK, 1–40.
41. Elliott, R.M., Brennan, B., Emerging phleboviruses. Curr. Opin. Virol. 5 (2014), 50–57.
42. Elliott, R.M., Bunyaviruses and climate change. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 15 (2009), 510–517.
43. Elliott, R.M., Orthobunyaviruses: recent genetic and structural insights. Nat. Rev. Microbiol. 12 (2014), 673–685.
44. Emonet, S.E., Urata, S., de la Torre, J.C., Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology 411 (2011), 416–425.
45. Eschli, B., Quirin, K., Wepf, A., Weber, J., Zinkernagel, R., Hengartner, H., Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins. J. Virol. 80 (2006), 5897–5907.
46. Fan, L., Briese, T., Lipkin, W.I., Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J. Virol. 84 (2010), 1785–1791.
47. Fearns, R., Peeples, M.E., Collins, P.L., Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome. Virology 236 (1997), 188–201.
48. Fehling, S.K., Lennartz, F., Strecker, T., Multifunctional nature of the arenavirus RING finger protein Z. Viruses 4 (2012), 2973–3011.
49. Fernández-García, Y., Reguera, J., Busch, C., Witte, G., Sánchez-Ramos, O., Betzel, C., Cusack, S., Günther, S., Reindl, S., Atomic structure and biochemical characterization of an RNA endonuclease in the N terminus of andes virus l protein. PLoS Pathog., 12, 2016, e1005635.
50. Fischer, S.A., Graham, M.B., Kuehnert, M.J., Kotton, C.N., Srinivasan, A., Marty, F.M., Comer, J.A., Guarner, J., Paddock, C.D., DeMeo, D.L., Shieh, W.J., Erickson, B.R., Bandy, U., DeMaria, A., Davis, J.P., Delmonico, F.L., Pavlin, B., Likos, A., Vincent, M.J., Sealy, T.K., Goldsmith, C.S., Jernigan, D.B., Rollin, P.E., Packard, M.M., Patel, M., Rowland, C., Helfand, R.F., Nichol, S.T., Fishman, J.A., Ksiazek, T., Zaki, S.R., Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354 (2006), 2235–2249.
51. Flusin, O., Vigne, S., Peyrefitte, C.N., Bouloy, M., Crance, J.-M., Iseni, F., Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin. Virol. J., 8, 2011, 249.
52. Franze-Fernández, M.T., Zetina, C., Iapalucci, S., Lucero, M.A., Bouissou, C., López, R., Rey, O., Daheli, M., Cohen, G.N., Zakin, M.M., Molecular structure and early events in the replication of Tacaribe arenavirus S RNA. Virus Res. 7 (1987), 309–324.
53. Freed, E.O., Viral late domains. J. Virol. 76 (2002), 4679–4687.
54. Freedman, D.O., Woodall, J., Emerging infectious diseases and risk to the traveler. Med. Clin. North Am. 83 (1999), 865–883 (v).
55. Frias-Staheli, N., Giannakopoulos, N.V., Kikkert, M., Taylor, S.L., Bridgen, A., Paragas, J.J., Richt, J.A., Rowland, R.R., Schmaljohn, C.S., Lenschow, D.J., Snijder, E.J., García-Sastre, A., Virgin, H.W., Ovarian tumor (OTU)-domain containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2 (2007), 404–416.
56. García Rada, A., First outbreak of Crimean-Congo haemorrhagic fever in western Europe kills one man in Spain. BMJ, 354, 2016, i4891.
57. Garcin, D., Kolakofsky, D., A novel mechanism for the initiation of Tacaribe arenavirus genome replication. J. Virol. 64 (1990), 6196–6203.
58. Garcin, D., Kolakofsky, D., Tacaribe arenavirus RNA synthesis in vitro is primer dependent and suggests an unusual model for the initiation of genome replication. J. Virol. 66 (1992), 1370–1376.
59. Garcin, D., Rochat, S., Kolakofsky, D., The Tacaribe arenavirus small zinc finger protein is required for both mRNA synthesis and genome replication. J. Virol. 67 (1993), 807–812.
60. Garcin, D., Lezzi, M., Dobbs, M., Elliott, R.M., Schmaljohn, C., Kang, C.Y., Kolakofsky, D., The 5’ ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J. Virol. 69 (1995), 5754–5762.
61. Geisbert, T.W., Jahrling, P.B., Exotic emerging viral diseases: progress and challenges. Nat. Med. 10 (2004), S110–21.
62. Gerlach, P., Malet, H., Cusack, S., Reguera, J., Structural insights into bunyavirus replication and its regulation by the vRNA promoter. Cell 161 (2015), 1267–1279.
63. Goldsmith, C.S., Elliott, L.H., Peters, C.J., Zaki, S.R., Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome. Arch. Virol. 140 (1995), 2107–2122.
64. Gowen, B.B., Juelich, T.L., Sefing, E.J., Brasel, T., Smith, J.K., Zhang, L., Tigabu, B., Hill, T.E., Yun, T., Pietzsch, C., Furuta, Y., Freiberg, A.N., Favipiravir (T-705) inhibits junín virus infection and reduces mortality in a Guinea pig model of argentine hemorrhagic fever. PLoS Negl. Trop. Dis., 7, 2013.
65. Guilligay, D., Tarendeau, F., Resa-Infante, P., Coloma, R., Crepin, T., Sehr, P., Lewis, J., Ruigrok, R.W.H., Ortin, J., Hart, D.J., Cusack, S., The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat. Struct. Mol. Biol. 15 (2008), 500–506.
66. Guilligay, D., Kadlec, J., Crépin, T., Lunardi, T., Bouvier, D., Kochs, G., Ruigrok, R.W.H., Cusack, S., Comparative structural and functional analysis of orthomyxovirus polymerase cap-snatching domains. PLoS One, 9, 2014, e84973.
67. Habjan, M., Andersson, I., Klingström, J., Schümann, M., Martin, A., Zimmermann, P., Wagner, V., Pichlmair, A., Schneider, U., Mühlberger, E., Mirazimi, A., Weber, F., Processing of genome 5(termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One, 3, 2008, e2032.
68. Hass, M., Golnitz, U., Muller, S., Becker-Ziaja, B., Gunther, S., Replicon system for Lassa virus. J. Virol. 78 (2004), 13793–13803.
69. Hass, M., Westerkofsky, M., Muller, S., Becker-Ziaja, B., Busch, C., Gunther, S., Mutational analysis of the lassa virus promoter. J. Virol. 80 (2006), 12414–12419.
70. Hass, M., Lelke, M., Busch, C., Becker-Ziaja, B., Gunther, S., Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome. J. Virol. 82 (2008), 10207–10217.
71. Hastie, K.M., Liu, T., Li, S., King, L.B., Ngo, N., Zandonatti, M.A., Woods, V.L., de la Torre, J.C., Saphire, E.O., Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 19365–19370.
72. Hastie, K.M., Zandonatti, M., Liu, T., Li, S., Woods, V.L., Saphire, E.O., Crystal structure of the oligomeric form of the Lassa virus matrix protein Z. J. Virol., 90, 2016 JVI, 02896–02815.
73. Hedil, M., Kormelink, R., Viral RNA silencing suppression: the enigma of bunyavirus NSs proteins. Viruses, 8, 2016.
74. Heinemann, P., Schmidt-Chanasit, J., Günther, S., The N terminus of Andes virus L protein suppresses mRNA and protein expression in mammalian cells. J. Virol. 87 (2013), 6975–6985.
75. Hermann, T., Strategies for the design of drugs targeting RNA and RNA-Protein complexes. Angew. Chem. Int. Ed. Engl. 39 (2000), 1890–1904.
76. Hoffmann, B., Scheuch, M., Höper, D., Jungblut, R., Holsteg, M., Schirrmeier, H., Eschbaumer, M., Goller, K.V., Wernike, K., Fischer, M., Breithaupt, A., Mettenleiter, T.C., Beer, M., Novel orthobunyavirus in cattle, europe, 2011. Emerg. Infect. Dis. 18 (2012), 469–472.
77. Hoogstraal, H., The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J. Med. Entomol. 15 (1979), 307–417.
78. Huang, Q., Shao, J., Lan, S., Zhou, Y., Xing, J., Dong, C., Liang, Y., Ly, H., In vitro and In vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions. J. Virol. 89 (2015), 6595–6607.
79. Ikegami, T., Won, S., Peters, C.J., Makino, S., Characterization of rift valley fever virus transcriptional terminations. J. Virol. 81 (2007), 8421–8438.
80. Isaacson, M., Viral hemorrhagic fever hazards for travelers in Africa. Clin. Infect. Dis. 33 (2001), 1707–1712.
81. James, T.W., Frias-Staheli, N., Bacik, J.-P., Levingston Macleod, J.M., Khajehpour, M., García-Sastre, A., Mark, B.L., Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 2222–2227.
82. Jiang, X., Huang, Q., Wang, W., Dong, H., Ly, H., Liang, Y., Dong, C., Structures of arenaviral nucleoproteins with triphosphate dsRNA reveal a unique mechanism of immune suppression. J. Biol. Chem. 288 (2013), 16949–16959.
83. Jin, H., Elliott, R.M., Non-viral sequences at the 5’ ends of Dugbe nairovirus S mRNAs. J. Gen. Virol. 74:Pt 10 (1993), 2293–2297.
84. Kentsis, A., Dwyer, E.C., Perez, J.M., Sharma, M., Chen, A., Pan, Z.Q., Borden, K., The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E. J. Mol. Biol., 312, 2001, 609.
85. Kentsis, A., Gordon, R.E., Borden, K.L.B., Self-assembly properties of a model RING domain. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 667–672.
86. Kilgore, P.E., Ksiazek, T.G., Rollin, P.E., Mills, J.N., Villagra, M.R., Montenegro, M.J., Costales, M.A., Paredes, L.C., Peters, C.J., Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin. Infect. Dis. 24 (1997), 718–722.
87. Kim, W.Y., Choi, W., Park, S.-W., Wang, E.B., Lee, W.-J., Jee, Y., Lim, K.S., Lee, H.-J., Kim, S.-M., Lee, S.-O., Choi, S.-H., Kim, Y.S., Woo, J.H., Kim, S.-H., Nosocomial transmission of severe fever with thrombocytopenia syndrome in Korea. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 60 (2015), 1681–1683.
88. Klemm, C., Reguera, J., Cusack, S., Zielecki, F., Kochs, G., Weber, F., Systems to establish bunyavirus genome replication in the absence of transcription. J. Virol. 87 (2013), 8205–8212.
89. Kohl, A., Dunn, E.F., Lowen, A.C., Elliott, R.M., Complementarity, sequence and structural elements within the 3’ and 5’ non-coding regions of the Bunyamwera orthobunyavirus S segment determine promoter strength. J. Gen. Virol. 85 (2004), 3269–3278.
90. Kolakofsky, D., dsRNA-ended genomes in orthobunyavirus particles and infected cells. Virology 489 (2016), 192–193.
91. Kranzusch, P.J., Whelan, S.P.J., Arenavirus Z protein controls viral RNA synthesis by locking a polymerase-promoter complex. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 19743–19748.
92. Kranzusch, P.J., Whelan, S.P., Architecture and regulation of negative-strand viral enzymatic machinery. RNA Biol. 9 (2012), 941–948.
93. Kranzusch, P.J., Schenk, A.D., Rahmeh, A.A., Radoshitzky, S.R., Bavari, S., Walz, T., Whelan, S.P.J., Assembly of a functional Machupo virus polymerase complex. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 20069–20074.
94. Kunz, S., Borrow, P., Oldstone, M.B., Receptor structure, binding, and cell entry of arenaviruses. Curr. Top. Microbiol. Immunol. 262 (2002), 111–137.
95. Kunz, S., Sevilla, N., Rojek, J.M., Oldstone, M.B., Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. Virology 325 (2004), 432–445.
96. Lee, K.J., de la Torre, J.C., Reverse genetics of arenaviruses. Curr. Top. Microbiol. Immunol. 262 (2002), 175–193.
97. Lee, K.J., Novella, I.S., Teng, M.N., Oldstone, M.B., de La Torre, J.C., NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J. Virol. 74 (2000), 3470–3477.
98. Lehmann, M., Pahlmann, M., Jérôme, H., Busch, C., Lelke, M., Günther, S., Role of the C terminus of Lassa virus L protein in viral mRNA synthesis. J. Virol. 88 (2014), 8713–8717.
99. Lelke, M., Brunotte, L., Busch, C., Günther, S., An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome. J. Virol. 84 (2010), 1934–1944.
100. Lopez, N., Jacamo, R., Franze-Fernandez, M.T., Transcription and RNA replication of tacaribe virus genome and antigenome analogs require N and L proteins: z protein is an inhibitor of these processes. J. Virol. 75 (2001), 12241–12251.
101. Ly, H.J., Ikegami, T., Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins. Virol. J., 13, 2016, 118.
102. Müller, R., Poch, O., Delarue, M., Bishop, D.H.L., Bouloy, M., Rift valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J. Gen. Virol. 75 (1994), 1345–1352.
103. Marklewitz, M., Zirkel, F., Kurth, A., Drosten, C., Junglen, S., Evolutionary and phenotypic analysis of live virus isolates suggests arthropod origin of a pathogenic RNA virus family. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 7536–7541.
104. Marq, J.-B., Kolakofsky, D., Garcin, D., Unpaired 5’ ppp-nucleotides, as found in arenavirus double-stranded RNA panhandles, are not recognized by RIG-I. J. Biol. Chem. 285 (2010), 18208–18216.
105. Marq, J.-B., Hausmann, S., Veillard, N., Kolakofsky, D., Garcin, D., Short double-stranded RNAs with an overhanging 5’ ppp-nucleotide, as found in arenavirus genomes, act as RIG-I decoys. J. Biol. Chem. 286 (2011), 6108–6116.
106. Martinez-Sobrido, L., Zuniga, E.I., Rosario, D., Garcia-Sastre, A., de la Torre, J.C., Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 80 (2006), 9192–9199.
107. Martinez-Sobrido, L., Giannakas, P., Cubitt, B., Garcia-Sastre, A., de la Torre, J.C., Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J. Virol. 81 (2007), 12696–12703.
108. Martinez-Sobrido, L., Emonet, S., Giannakas, P., Cubitt, B., Garcia-Sastre, A., de la Torre, J.C., Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 83 (2009), 11330–11340.
109. Martinez-Valdebenito, C., Calvo, M., Vial, C., Mansilla, R., Marco, C., Palma, R.E., Vial, P.A., Valdivieso, F., Mertz, G., Ferrés, M., Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011. Emerg. Infect. Dis. 20 (2014), 1629–1636.
110. McCormick, J.B., Fisher-Hoch, S.P., Lassa fever. Oldstone, M.B., (eds.) Arenaviruses I, 2002, Springer-Verlag, Berlin, Heidelberg, New York, 75–110.
111. McKee, K.T., Huggins, J.W., Trahan, C.J., Mahlandt, B.G., Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever. Antimicrob. Agents Chemother. 32 (1988), 1304–1309.
112. Mets, M.B., Barton, L.L., Khan, A.S., Ksiazek, T.G., Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis. Am. J. Ophthalmol. 130 (2000), 209–215.
113. Meyer, B.J., de la Torre, J.C., Southern, P.J., Arenaviruses: genomic RNAs, transcription, and replication. Curr. Top. Microbiol. Immunol. 262 (2002), 139–149.
114. Mohamed, M., McLees, A., Elliott, R.M., Viruses in the Anopheles A, Anopheles B, and Tete serogroups in the Orthobunyavirus genus (family Bunyaviridae) do not encode an NSs protein. J. Virol. 83 (2009), 7612–7618.
115. Montgomery, E., On a tick-borne gastro-enteritis of sheep and goats occurring in British East Africa. J. Comp. Pathol. 30 (1917), 28–57.
116. Morin, B., Coutard, B., Lelke, M., Ferron, F., Kerber, R., Jamal, S., Frangeul, A., Baronti, C., Charrel, R., de Lamballerie, X., Vonrhein, C., Lescar, J., Bricogne, G., Günther, S., Canard, B., The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog., 6, 2010, e1001038.
117. Neuman, B.W., Adair, B.D., Burns, J.W., Milligan, R.A., Buchmeier, M.J., Yeager, M., Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis. J. Virol. 79 (2005), 3822–3830.
118. Oldstone, M.B., Biology and pathogenesis of lymphocytic choriomeningitis virus infection, in: oldstone M.B. (Ed.). Arenaviruses, 2002, 83–118.
119. Ortiz-Riano, E., Cheng, B.Y., Carlos de la Torre, J., Martinez-Sobrido, L., Arenavirus reverse genetics for vaccine development. J. Gen. Virol. 94 (2013), 1175–1188.
120. Osborne, J.C., Elliott, R.M., RNA binding properties of bunyamwera virus nucleocapsid protein and selective binding to an element in the 5′ terminus of the negative-sense S segment. J. Virol. 74 (2000), 9946–9952.
121. Padula, P.J., Edelstein, A., Miguel, S.D., López, N.M., Rossi, C.M., Rabinovich, R.D., Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 241 (1998), 323–330.
122. Palacios, G., Druce, J., Du, L., Tran, T., Birch, C., Briese, T., Conlan, S., Quan, P.L., Hui, J., Marshall, J., Simons, J.F., Egholm, M., Paddock, C.D., Shieh, W.J., Goldsmith, C.S., Zaki, S.R., Catton, M., Lipkin, W.I., A new arenavirus in a cluster of fatal transplant-associated diseases. N. Engl. J. Med. 358 (2008), 991–998.
123. Parker, W.B., Metabolism and antiviral activity of ribavirin. Virus Res. 107 (2005), 165–171.
124. Perez, M., de la Torre, J.C., Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). J. Virol., 2002 (in press.
125. Perez, M., de la Torre, J.C., Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 77 (2003), 1184–1194.
126. Perez, M., Craven, R.C., de la Torre, J.C., The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 12978–12983.
127. Perez, M., Greenwald, D.L., de la Torre, J.C., Myristoylation of the RING finger Z protein is essential for arenavirus budding. J. Virol. 78 (2004), 11443–11448.
128. Peters, C.J., Lymphocytic choriomeningitis virus–an old enemy up to new tricks. N. Engl. J. Med. 354 (2006), 2208–2211.
129. Pettersson, R.F., Melin, L., Synthesis, assembly, and intracellular transport of bunyaviridae membrane proteins. Elliott, R.M., (eds.) The Bunyaviridae, 1996, Springer, US, Boston, MA, 159–188.
130. Pflug, A., Guilligay, D., Reich, S., Cusack, S., Structure of influenza A polymerase bound to the viral RNA promoter. Nature 516 (2014), 355–360.
131. Pflug, A., Lukarska, M., Resa-Infante, P., Reich, S., Cusack, S., Structural insights into RNA synthesis by the influenza virus transcription replication machine. Virus Res. 234 (2017), 103–117.
132. Pinschewer, D.D., Perez, M., de la Torre, J.C., Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J. Virol. 77 (2003), 3882–3887.
133. Pinschewer, D.D., Perez, M., de la Torre, J.C., Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation. J. Virol. 79 (2005), 4519–4526.
134. Qi, X., Lan, S., Wang, W., Schelde, L.M., Dong, H., Wallat, G.D., Ly, H., Liang, Y., Dong, C., Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468 (2010), 779–783.
135. Radoshitzky, S.R., Abraham, J., Spiropoulou, C.F., Kuhn, J.H., Nguyen, D., Li, W., Nagel, J., Schmidt, P.J., Nunberg, J.H., Andrews, N.C., Farzan, M., Choe, H., Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446 (2007), 92–96 (Epub 2007 Feb 7).
136. Radoshitzky, S.R., Bào, Y., Buchmeier, M.J., Charrel, R.N., Clawson, A.N., Clegg, C.S., DeRisi, J.L., Emonet, S., Gonzalez, J.-P., Kuhn, J.H., Lukashevich, I.S., Peters, C.J., Romanowski, V., Salvato, M.S., Stenglein, M.D., de la Torre, J.C., Past, present, and future of arenavirus taxonomy. Arch. Virol. 160 (2015), 1851–1874.
137. Raju, R., Kolakofsky, D., The ends of La Crosse virus genome and antigenome RNAs within nucleocapsids are base paired. J. Virol. 63 (1989), 122–128.
138. Raju, R., Raju, L., Hacker, D., Garcin, D., Compans, R., Kolakofsky, D., Nontemplated bases at the 5’ ends of Tacaribe virus mRNAs. Virology 174 (1990), 53–59.
139. Reguera, J., Carreira, A., Riolobos, L., Almendral, J.M., Mateu, M.G., Role of interfacial amino acid residues in assembly, stability, and conformation of a spherical virus capsid. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 2724–2729.
140. Reguera, J., Weber, F., Cusack, S., Bunyaviridae RNA polymerases (L-Protein) have an N-Terminal, influenza-Like endonuclease domain, essential for viral cap-Dependent transcription. PLoS Pathog., 6, 2010, e1001101.
141. Reguera, J., Malet, H., Weber, F., Cusack, S., Structural basis for encapsidation of genomic RNA by La Crosse Orthobunyavirus nucleoprotein. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 7246–7251.
142. Reguera, J., Cusack, S., Kolakofsky, D., Segmented negative strand RNA virus nucleoprotein structure. Curr. Opin. Virol. 5 (2014), 7–15.
143. Reguera, J., Gerlach, P., Cusack, S., Towards a structural understanding of RNA synthesis by negative strand RNA viral polymerases. Curr. Opin. Struct. Biol. 36 (2016), 75–84 (d).
144. Reguera, J., Gerlach, P., Rosenthal, M., Gaudon, S., Coscia, F., Günther, S., Cusack, S., Comparative structural and functional analysis of bunyavirus and arenavirus cap-Snatching endonucleases. PLoS Pathog., 12, 2016, e1005636.
145. Reich, S., Guilligay, D., Pflug, A., Malet, H., Berger, I., Crépin, T., Hart, D., Lunardi, T., Nanao, M., Ruigrok, R.W.H., Cusack, S., Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature 516 (2014), 361–366.
146. Richmond, J.K., Baglole, D.J., Lassa fever: epidemiology, clinical features, and social consequences. BMJ 327 (2003), 1271–1275.
147. Ruiz-Jarabo, C.M., Ly, C., Domingo, E., de la Torre, J.C., Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308 (2003), 37–47.
148. Safronetz, D., Rosenke, K., Westover, J.B., Martellaro, C., Okumura, A., Furuta, Y., Geisbert, J., Saturday, G., Komeno, T., Geisbert, T.W., Feldmann, H., Gowen, B.B., The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset. Sci. Rep., 5, 2015.
149. Salanueva, I.J., Novoa, R.R., Cabezas, P., Lopez-Iglesias, C., Carrascosa, J.L., Elliott, R.M., Risco, C., Polymorphism and structural maturation of bunyamwera virus in golgi and post-Golgi compartments. J. Virol. 77 (2003), 1368–1381.
150. Sanchez, A.B., de la Torre, J.C., Genetic and biochemical evidence for an oligomeric structure of the functional L polymerase of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 79 (2005), 7262–7268.
151. Saunders, A.A., Ting, J.P., Meisner, J., Neuman, B.W., Perez, M., de la Torre, J.C., Buchmeier, M.J., Mapping the landscape of the lymphocytic choriomeningitis virus stable signal peptide reveals novel functional domains. J. Virol. 81 (2007), 5649–5657.
152. Scharton, D., Bailey, K.W., Vest, Z., Westover, J.B., Kumaki, Y., Van Wettere, A., Furuta, Y., Gowen, B.B., Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Antiviral Res. 104 (2014), 84–92.
153. Schoen, A., Weber, F., Orthobunyaviruses and innate immunity induction: alieNSs vs. PredatoRRs. Eur. J. Cell Biol 94 (2015), 384–390 (Mechanisms of cellular compartmentalisation and the relevance for disease).
154. Schreur, P.J.W., Kortekaas, J., Single-Molecule FISH reveals non-selective packaging of rift valley fever virus genome segments. PLoS Pathog., 12, 2016, e1005800.
155. Sears, P., Wong, C.H., Toward automated synthesis of oligosaccharides and glycoproteins. Science 291 (2001), 2344–2350.
156. Shi, X., Kohl, A., Léonard, V.H.J., Li, P., McLees, A., Elliott, R.M., Requirement of the N-Terminal region of orthobunyavirus nonstructural protein NSm for virus assembly and morphogenesis. J. Virol. 80 (2006), 8089–8099.
157. Smallwood, S., Moyer, S.A., The L polymerase protein of parainfluenza virus 3 forms an oligomer and can interact with the heterologous Sendai virus L, P and C proteins. Virology 318 (2004), 439–450.
158. Smallwood, S., Cevik, B., Moyer, S.A., Intragenic complementation and oligomerization of the L subunit of the sendai virus RNA polymerase. Virology 304 (2002), 235–245.
159. Strecker, T., Eichler, R., ter Meulen, J., Weissenhorn, W., Dieter Klenk, H., Garten, W., Lenz, O., Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J. Virol. 77 (2003), 10700–10705.
160. Strecker, T., Maisa, A., Daffis, S., Eichler, R., Lenz, O., Garten, W., The role of myristoylation in the membrane association of the Lassa virus matrix protein Z. Virol. J., 3, 2006, 93.
161. Sucheck, S.J., Shue, Y.K., Combinatorial synthesis of aminoglycoside libraries. Curr. Opin. Drug Discov. Devel. 4 (2001), 462–470.
162. Sucheck, S.J., Wong, C.H., RNA as a target for small molecules. Curr. Opin. Chem. Biol. 4 (2000), 678–686.
163. Talmon, Y., Prasad, B.V., Clerx, J.P., Wang, G.J., Chiu, W., Hewlett, M.J., Electron microscopy of vitrified-hydrated La Crosse virus. J. Virol. 61 (1987), 2319–2321.
164. Thierry, E., Guilligay, D., Kosinski, J., Bock, T., Gaudon, S., Round, A., Pflug, A., Hengrung, N., El Omari, K., Baudin, F., Hart, D.J., Beck, M., Cusack, S., Influenza polymerase can adopt an alternative configuration involving a radical repacking of PB2 domains. Mol. Cell 61 (2016), 125–137.
165. Tilston-Lunel, N.L., Acrani, G.O., Randall, R.E., Elliott, R.M., Generation of recombinant oropouche viruses lacking the nonstructural protein NSm or NSs. J. Virol. 90 (2016), 2616–2627.
166. Urata, S., Noda, T., Kawaoka, Y., Yokosawa, H., Yasuda, J., Cellular factors required for Lassa virus budding. J. Virol. 80 (2006), 4191–4195.
167. Vaheri, Vapalahti, Bunyaviridae infections and their diagnostics: hantavirus, nairovirus, orthobunyavirus and phlebovirus genera. Elliott, R.M., Plyusnin, A.R.M., (eds.) Bunyaviridae, Molecular and Cellular Biology, 2011, Caister Academic Press, Norkfolk, UK, 193–206.
168. Vieth, S., Torda, A.E., Asper, M., Schmitz, H., Gunther, S., Sequence analysis of l RNA of lassa virus. Virology 318 (2004), 153–168.
169. Volpon, L., Osborne, M.J., Borden, K.L.B., NMR assignment of the arenaviral protein Z from Lassa fever virus. Biomol. NMR Assign. 2 (2008), 81–84.
170. Volpon, L., Osborne, M.J., Capul, A., a de la Torre, J.C., Borden, K.L.B., Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 5441–5446.
171. Wallat, G.D., Huang, Q., Wang, W., Dong, H., Ly, H., Liang, Y., Dong, C., High-resolution structure of the N-terminal endonuclease domain of the Lassa virus L polymerase in complex with magnesium ions. PLoS One, 9, 2014, e87577.
172. Wang, S., Huber, P.W., Cui, M., Czarnik, A.W., Mei, H.Y., Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism. Biochemistry (Mosc.) 37 (1998), 5549–5557.
173. Wang, H., Vaheri, A., Weber, F., Plyusnin, A., Old World hantaviruses do not produce detectable amounts of dsRNA in infected cells and the 5’ termini of their genomic RNAs are monophosphorylated. J. Gen. Virol. 92 (2011), 1199–1204.
174. West, B.R., Hastie, K.M., Saphire, E.O., Structure of the LCMV nucleoprotein provides a template for understanding arenavirus replication and immunosuppression. Acta Crystallogr Biol Crystallogr 70 (2014), 1764–1769.
175. Westover, J.B., Sefing, E.J., Bailey, K.W., Van Wettere, A.J., Jung, K.-H., Dagley, A., Wandersee, L., Downs, B., Smee, D.F., Furuta, Y., Bray, M., Gowen, B.B., Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses. Antiviral Res. 126 (2016), 62–68.
176. Won, S., Ikegami, T., Peters, C.J., Makino, S., NSm protein of rift valley fever virus suppresses virus-Induced apoptosis. J. Virol. 81 (2007), 13335–13345.
177. Xing, J., Ly, H., Liang, Y., The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-i-like receptor-dependent interferon production. J. Virol. 89 (2015), 2944–2955.
178. Ye, X.-S., Zhang, L.H., Aminoglycoside mimetics as small-molecule drugs targeting RNA. Curr. Med. Chem. 9 (2002), 929–939.
179. York, J., Nunberg, J.H., Role of the stable signal peptide of Junin arenavirus envelope glycoprotein in pH-dependent membrane fusion. J. Virol. 80 (2006), 7775–7780.
180. York, J., Nunberg, J.H., Distinct requirements for signal peptidase processing and function in the stable signal peptide subunit of the Junin virus envelope glycoprotein. Virology 359 (2007), 72–81.
181. York, J., Nunberg, J.H., Intersubunit interactions modulate pH-induced activation of membrane fusion by the Junin virus envelope glycoprotein GPC. J. Virol. 83 (2009), 4121–4126.
182. York, J., Romanowski, V., Lu, M., Nunberg, J.H., The signal peptide of the Junin arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex. J. Virol. 78 (2004), 10783–10792.
183. Young, P.R., Howard, C.R., Fine structure analysis of pichinde virus nucleocapsids. J. Gen. Virol. 64 (1983), 833–842.
184. Yu, X.-J., Liang, M.-F., Zhang, S.-Y., Liu, Y., Li, J.-D., Sun, Y.-L., Zhang, L., Zhang, Q.-F., Popov, V.L., Li, C., Qu, J., Li, Q., Zhang, Y.-P., Hai, R., Wu, W., Wang, Q., Zhan, F.-X., Wang, X.-J., Kan, B., Wang, S.-W., Wan, K.-L., Jing, H.-Q., Lu, J.-X., Yin, W.-W., Zhou, H., Guan, X.-H., Liu, J.-F., Bi, Z.-Q., Liu, G.-H., Ren, J., Wang, H., Zhao, Z., Song, J.-D., He, J.-R., Wan, T., Zhang, J.-S., Fu, X.-P., Sun, L.-N., Dong, X.-P., Feng, Z.-J., Yang, W.-Z., Hong, T., Zhang, Y., Walker, D.H., Wang, Y., Li, D.-X., Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med. 364 (2011), 1523–1532.
185. Yuan, P., Bartlam, M., Lou, Z., Chen, S., Zhou, J., He, X., Lv, Z., Ge, R., Li, X., Deng, T., Fodor, E., Rao, Z., Liu, Y., Crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site. Nature 458 (2009), 909–913.
186. Zapp, M.L., Stern, S., Green, M.R., Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell 74 (1993), 969–978.
187. Zhang, Y., Li, L., Liu, X., Dong, S., Wang, W., Huo, T., Guo, Y., Rao, Z., Yang, C., Crystal structure of Junin virus nucleoprotein. J. Gen. Virol. 94 (2013), 2175–2183.
188. Zhao, L., Zhai, S., Wen, H., Cui, F., Chi, Y., Wang, L., Xue, F., Wang, Q., Wang, Z., Zhang, S., Song, Y., Du, J., Yu, X., Severe fever with thrombocytopenia syndrome virus, Shandong Province, China. Emerg. Infect. Dis. 18 (2012), 963–965.
189. Zinkernagel, R.M., Lymphocytic choriomeningitis virus and immunology. Curr. Top. Microbiol. Immunol. 263 (2002), 1–5.
190. van Eeden, P.J., Joubert, J.R., van de Wal, B.W., King, J.B., de Kock, A., Groenewald, J.H., A nosocomial outbreak of crimean-Congo haemorrhagic fever at tygerberg hospital: part I. clinical features. South Afr. Med. J. Suid-Afr. Tydskr. Vir Geneeskd. 68 (1985), 711–717.